BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2690296)

  • 1. Evolution of antibiotic therapy for infection in neutropenic patients: studies at M. D. Anderson Hospital.
    Bodey GP
    Rev Infect Dis; 1989; 11 Suppl 7():S1582-90. PubMed ID: 2690296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro models for the study of combination antibiotic therapy in neutropenic patients.
    Zinner SH; Dudley M; Blaser J
    Am J Med; 1986 Jun; 80(6B):156-60. PubMed ID: 3728526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy for empirical management of febrile neutropenic patients.
    Rubin M; Pizzo PA
    NCI Monogr; 1990; (9):111-6. PubMed ID: 2160613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patients.
    Jones P; Rolston K; Fainstein V; Elting L; Bodey GP
    Rev Infect Dis; 1985; 7 Suppl 4():S741-6. PubMed ID: 3909332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of empiric antibiotic therapy for the febrile neutropenic patient.
    Schimpff SC
    Rev Infect Dis; 1985; 7 Suppl 4():S734-40. PubMed ID: 3878564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
    Anaissie EJ; Fainstein V; Bodey GP; Rolston K; Elting L; Kantarjian H; Cabanillas F; McCredie KB
    Am J Med; 1988 Mar; 84(3 Pt 2):581-9. PubMed ID: 3279774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
    Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
    Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.
    Rolston KV; Bodey GP; Elting L
    Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC
    Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia.
    Pizzo PA; Hathorn JW; Hiemenz J; Browne M; Commers J; Cotton D; Gress J; Longo D; Marshall D; McKnight J
    N Engl J Med; 1986 Aug; 315(9):552-8. PubMed ID: 3526155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
    Feld R; Louie TJ; Mandell L; Bow EJ; Robson HG; Chow A; Belch A; Miedzinski L; Rachlis A; Pater J
    Arch Intern Med; 1985 Jun; 145(6):1083-8. PubMed ID: 3890789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients.
    Bodey GP; Feld R; Burgess MA
    Am J Med Sci; 1976; 271(2):179-86. PubMed ID: 773180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of infection in granulopenic patients. Lessons from international studies].
    Beytout J; Travade P; Petit MF
    Presse Med; 1988 Oct; 17(37):1950-3. PubMed ID: 2973594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of bacterial infections in severely neutropenic subjects.
    Vincent PC; Fabre S; Jennis F
    Med J Aust; 1977 Oct; 2(3 Pt 2 Suppl):30-3. PubMed ID: 244772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of choice for the empiric treatment of the febrile neutropenic patient.
    Barriere SL
    Drug Intell Clin Pharm; 1986 Oct; 20(10):767-9. PubMed ID: 3769764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
    Walsh TJ; Schimpff SC
    Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aztreonam therapy in neutropenic patients with cancer.
    Jones PG; Rolston KV; Fainstein V; Elting L; Walters RS; Bodey GP
    Am J Med; 1986 Aug; 81(2):243-8. PubMed ID: 3526885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of aminoglycosides in neutropenic patients.
    Cometta A; Glauser MP
    Schweiz Med Wochenschr Suppl; 1996; 76():21S-27S. PubMed ID: 8677415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic therapy for gram-negative bacteremia.
    Calandra T; Cometta A
    Infect Dis Clin North Am; 1991 Dec; 5(4):817-34. PubMed ID: 1783770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.